Eggen B M, Lamvik J O, Unsgaard G
Scand J Haematol. 1982 Nov;29(5):381-8. doi: 10.1111/j.1600-0609.1982.tb00612.x.
There was no difference in monocyte-mediated cytotoxicity between monocytes from patients with multiple myeloma or malignant lymphomas and monocytes from control persons after in vitro culture for 5 d. Cytostatic and cytolytic ability of lymphokine-activated monocytes cultured in medium with patient serum was significantly depressed compared to the ability of monocytes cultured with normal serum. A similar depression of cytostasis was found with non-activated monocytes of both patient and control origin. Sera from myeloma and lymphoma patients impaired the monocyte-mediated cytotoxicity equally.
多发性骨髓瘤或恶性淋巴瘤患者的单核细胞与对照者的单核细胞在体外培养5天后,单核细胞介导的细胞毒性没有差异。与用正常血清培养的单核细胞相比,在含有患者血清的培养基中培养的淋巴因子激活的单核细胞的细胞抑制和细胞溶解能力明显降低。在患者和对照来源的未激活单核细胞中也发现了类似的细胞抑制降低情况。骨髓瘤和淋巴瘤患者的血清对单核细胞介导的细胞毒性的损害程度相同。